自身免疫性脑炎临床评估量表(CASE)的研发
本研究旨在开发并验证用于评估自身免疫性脑炎(AE)严重程度的新量表CASE。量表含9个条目,每项0-3分,总分0-27分。开发队列(n=50)显示良好的评定者间和评定者内信度(ICC=0.97和0.96),与改良Rankin量表高度相关(r=0.86,p<0.001),内部一致性可接受(Cronbach α=0.88)。验证队列(n=38)证实高评定者间信度(ICC=0.99)和内部一致性(Cronbach α=0.92)。
要点
- CASE量表包含9个临床条目,总分0-27分,用于评估AE严重程度。
- 量表在开发与验证队列中均显示优良的信度与效度。
- CASE与改良Rankin量表高度相关,适合临床实践应用。
核心结论
- CASE是用于自身免疫性脑炎的新型临床量表,具有高水平的临床计量学特性,适合临床实践并可能克服现有结局量表的局限性。
研究设计与样本
- 量表条目由专家小组生成并根据内容效度比选择;开发队列纳入50例AE患者评估可接受性、重现性、内部一致性和结构效度;验证队列为另一独立队列38例AE患者。
主要发现
- 开发出含9个条目(癫痫发作、记忆障碍、精神症状、意识障碍、语言问题、运动障碍/肌张力障碍、步态不稳和共济失调、脑干功能障碍、肌无力)的CASE量表,每项0-3分,总分0-27分。
- 开发队列中总量表评定者间信度ICC=0.97,评定者内信度ICC=0.96,与改良Rankin量表相关r=0.86(p<0.001),内部一致性Cronbach α=0.88。
- 验证队列中评定者间信度ICC=0.99,内部一致性Cronbach α=0.92。
关键数值与推荐
- CASE量表总分范围为0至27分,每个条目最高3分。
- 开发队列评定者间信度ICC=0.97,评定者内信度ICC=0.96。
- 与改良Rankin量表相关系数r=0.86(p<0.001)。
- 开发队列Cronbach α=0.88,验证队列Cronbach α=0.92。
- 验证队列评定者间信度ICC=0.99。
临床怎么用
- CASE可用于临床实践中评估自身免疫性脑炎患者的严重程度,并可能替代现有结局量表。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There is no scale for rating the severity of autoimmune encephalitis (AE). In this study, we aimed to develop a novel scale for rating severity in patients with diverse AE syndromes and to verify the reliability and validity of the developed scale. METHODS: The key items were generated by a panel of experts and selected according to content validity ratios. The developed scale was initially applied to 50 patients with AE (development cohort) to evaluate its acceptability, reproducibility, internal consistency, and construct validity. Then, the scale was applied to another independent cohort (validation cohort, n = 38). RESULTS: A new scale consisting of 9 items (seizure, memory dysfunction, psychiatric symptoms, consciousness, language problems, dyskinesia/dystonia, gait instability and ataxia, brainstem dysfunction, and weakness) was developed. Each item was assigned a value of up to 3 points. The total score could therefore range from 0 to 27. We named the scale the Clinical Assessment Scale in Autoimmune Encephalitis (CASE). The new scale showed excellent interobserver (intraclass correlation coefficient [ICC] = 0.97) and intraobserver (ICC = 0.96) reliability for total scores, was highly correlated with modified Rankin scale (r = 0.86, p < 0.001), and had acceptable internal consistency (Cronbach α = 0.88). Additionally, in the validation cohort, the scale showed high interobserver reliability (ICC = 0.99) and internal consistency (Cronbach α = 0.92). INTERPRETATION: CASE is a novel clinical scale for AE with a high level of clinimetric properties. It would be suitable for application in clinical practice and might help overcome the limitations of current outcome scales for AE. ANN NEUROL 2019;85:352-358.
引用
- Lim JA, Lee ST, Moon J, et al. Development of the clinical assessment scale in autoimmune encephalitis. Ann Neurol. 2019. PMID: 30675918. doi:10.1002/ana.25421
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。